LSL Pharma Group Inc (LSL) Stock Price & Analysis

2 Followers

LSL Stock Chart & Stats

CA$0.29-CA$0.02(-8.06%)

At close: Nov 10 4:00 PM EST

Day’s Range: CAD 0.29 - CAD 0.32
52-Week Range: CAD 0.26 - CAD 0.56
Previous Close: CAD 0.31
Volume: N/A
Average Volume (3M): 36.22K
Market Cap: CAD 39.29M
Enterprise Value: CAD 89.55M
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): CAD 10.57M
Price to Earnings (P/E): ―
Beta: 0.58
Next Earnings: Dec 01, 2026 (Est.)
EPS Estimate: -0.02
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

LSL Pharma Group Inc News

LSL Pharma to Showcase Its Integrated Pharma Platform at Planet MicroCap Toronto 2026

LSL Pharma Group Inc ( ($TSE:LSL) ) has shared an update. LSL Pharma Group Inc., a Canadian integrated pharmaceutical company, develops and manufactures sterile ophthalmic drugs as well as pharmaceutical,

2w agoLSL

LSL Pharma Delivers Record Q2 Revenue as Eye-Care and Private Label Drive Growth

LSL Pharma Group Inc ( ($TSE:LSL) ) has provided an announcement. LSL Pharma Group reported record second-quarter 2026 revenues of $14.6 million, up 103% year over year, driven by strong

2M agoLSL

LSL Pharma to Highlight Growth Story at 2026 Bloom Burton Healthcare Investor Conference

LSL Pharma Group Inc ( ($TSE:LSL) ) has issued an announcement. LSL Pharma Group Inc., a Canadian integrated pharmaceutical manufacturer specializing in sterile ophthalmic products and a range of pharmaceutical,

7M agoLSL

LSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal

The latest announcement is out from LSL Pharma Group Inc ( ($TSE:LSL) ). LSL Pharma Group’s Juno OTC unit has signed a binding term sheet with Instapill Private Limited to

7M agoLSL

LSL Pharma Grants 960,000 Stock Options to Directors, Executives and Staff

LSL Pharma Group Inc ( ($TSE:LSL) ) has shared an update. LSL Pharma Group has granted a total of 960,000 stock options to its non-executive directors, executives and employees as

9M agoLSL

LSL Pharma Wins FDA Nod for Ophthalmic Ointment Manufacturing, Unlocking U.S. Market Access

LSL Pharma Group Inc ( ($TSE:LSL) ) has shared an update. LSL Pharma Group has obtained U.S. FDA certification for the manufacturing of ophthalmic ointments at its Steri-Med Pharma facility,

9M agoLSL

LSL Pharma Closes Juno OTC Acquisition and Completes $12 Million Financing Package

LSL Pharma Group Inc ( ($TSE:LSL) ) has provided an announcement. LSL Pharma Group Inc. has completed the $5 million acquisition of Toronto-based Juno OTC Inc. from Juno Pharmaceuticals LP,

10M agoLSL

LSL Pharma Raises $10 Million and Moves to Acquire Juno OTC

LSL Pharma Group Inc ( ($TSE:LSL) ) has provided an update. LSL Pharma Group has closed a $10 million initial tranche of an upsized $12 million private placement of unsecured

10M agoLSL

LSL Pharma Group Acquires Juno OTC Inc. and Secures $11M Fundraising

LSL Pharma Group Inc ( ($TSE:LSL) ) just unveiled an update. LSL Pharma Group Inc. has announced the acquisition of Juno OTC Inc., a Toronto-based subsidiary of Juno Pharmaceuticals LP,

10M agoLSL

LSL Pharma Group Achieves Record Q3 Revenues and Expands Operations

LSL Pharma Group Inc ( ($TSE:LSL) ) has issued an announcement. LSL Pharma Group Inc. reported its fourth consecutive record quarterly revenues for Q3 2025, with a significant increase in

11M agoLSL

LSL FAQ

What was LSL Pharma Group Inc’s price range in the past 12 months?

LSL Pharma Group Inc lowest stock price was C$0.26 and its highest was C$0.56 in the past 12 months.

What is LSL Pharma Group Inc’s market cap?

LSL Pharma Group Inc’s market cap is C$39.29M.

When is LSL Pharma Group Inc’s upcoming earnings report date?

LSL Pharma Group Inc’s next earnings report is estimated for Dec 01, 2026 (not yet confirmed), which is in 20 days.

How were LSL Pharma Group Inc’s earnings last quarter?

LSL Pharma Group Inc released its earnings results on Aug 25, 2026. The company reported -C$0.01 earnings per share for the quarter.

Is LSL Pharma Group Inc overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does LSL Pharma Group Inc pay dividends?

LSL Pharma Group Inc does not currently pay dividends.

What is LSL Pharma Group Inc’s EPS estimate?

LSL Pharma Group Inc’s EPS estimate is -0.02.

How many shares outstanding does LSL Pharma Group Inc have?

LSL Pharma Group Inc has 126,729,820 shares outstanding.

What happened to LSL Pharma Group Inc’s price movement after its last earnings report?

LSL Pharma Group Inc reported an EPS of -C$0.01 in its last earnings report. Following the earnings report the stock price went down -4.286%.

Which hedge fund is a major shareholder of LSL Pharma Group Inc?

Currently, no hedge funds are holding shares in TSE:LSL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description